Evercore ISI reiterated their buy rating on shares of electroCore (NASDAQ:ECOR) in a research note published on Wednesday morning, AnalystRatings.com reports. The firm currently has a $9.00 price objective on the stock.
Several other analysts have also commented on ECOR. JMP Securities decreased their price objective on electroCore to $10.00 and set a positive rating for the company in a report on Thursday, August 15th. BTIG Research reiterated a hold rating on shares of electroCore in a report on Wednesday, August 14th. Noble Financial reiterated a buy rating and set a $11.00 price objective on shares of electroCore in a report on Thursday, August 15th. ValuEngine upgraded electroCore from a hold rating to a buy rating in a report on Thursday, August 1st. Finally, Zacks Investment Research lowered electroCore from a buy rating to a hold rating in a report on Tuesday, October 15th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. electroCore currently has a consensus rating of Hold and a consensus price target of $6.95.
Shares of ECOR traded up $0.10 during mid-day trading on Wednesday, reaching $1.58. 185,600 shares of the company’s stock traded hands, compared to its average volume of 144,152. The company has a debt-to-equity ratio of 0.04, a current ratio of 6.63 and a quick ratio of 5.93. The stock has a market cap of $43.80 million, a P/E ratio of -1.33 and a beta of 2.42. The stock’s 50-day moving average is $1.95 and its two-hundred day moving average is $2.42. electroCore has a 12 month low of $1.23 and a 12 month high of $10.24.
Institutional investors and hedge funds have recently modified their holdings of the company. Parametric Portfolio Associates LLC purchased a new position in electroCore in the 2nd quarter worth $99,000. Bfsg LLC raised its stake in electroCore by 205.9% in the 2nd quarter. Bfsg LLC now owns 52,000 shares of the company’s stock worth $104,000 after acquiring an additional 35,000 shares during the last quarter. Vanguard Group Inc. raised its stake in electroCore by 4.8% in the 2nd quarter. Vanguard Group Inc. now owns 664,936 shares of the company’s stock worth $1,330,000 after acquiring an additional 30,671 shares during the last quarter. Bronfman E.L. Rothschild L.P. purchased a new position in electroCore in the 2nd quarter worth $50,000. Finally, BlackRock Inc. raised its stake in electroCore by 3.7% in the 2nd quarter. BlackRock Inc. now owns 575,248 shares of the company’s stock worth $1,150,000 after acquiring an additional 20,536 shares during the last quarter. Hedge funds and other institutional investors own 9.91% of the company’s stock.
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: What Factors Can Affect Return on Equity?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.